Mira T. Keddis

Nephrology

13400 E Shea Blvd
Scottsdale, AZ 85259

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

The Impact of Distressed Community Index on Stone Burden, Prevention, and Quality of Life in Patients With Nephrolithiasis.

The Impact of Distressed Community Index on Stone Burden, Prevention, and Quality of Life in Patients With Nephrolithiasis.

Journal: Urology

Published: April 03, 2026

Composite Phenotype: Recurrent Nephrolithiasis and Chronic Kidney Disease in an Adult with Biallelic SLC34A3 and Monoallelic SLC3A1 Pathogenic Variants - Who Is "The Culprit"?

Composite Phenotype: Recurrent Nephrolithiasis and Chronic Kidney Disease in an Adult with Biallelic SLC34A3 and Monoallelic SLC3A1 Pathogenic Variants - Who Is "The Culprit"?

Journal: Kidney & blood pressure research

Published: August 15, 2025

Treatment Deferral and Coping Mechanisms Associated With Nephrolithiasis-related Financial Toxicity.

Treatment Deferral and Coping Mechanisms Associated With Nephrolithiasis-related Financial Toxicity.

Journal: Urology

Published: April 19, 2025

Gut to Stone: The Woes of Malabsorption and Kidney Stone Growth.

Gut to Stone: The Woes of Malabsorption and Kidney Stone Growth.

Journal: Kidney international reports

Published: April 13, 2025

Kidney Stone Events and ESKD Incidence in Patients with Enteric Hyperoxaluria from Diverse Enteric Etiologies.

Kidney Stone Events and ESKD Incidence in Patients with Enteric Hyperoxaluria from Diverse Enteric Etiologies.

Journal: Kidney360

Published: April 03, 2025

Do Factors Influencing Acceptance of Kidney Stone Formers as Donors Predict Subsequent Stone Events?

Do Factors Influencing Acceptance of Kidney Stone Formers as Donors Predict Subsequent Stone Events?

Journal: Clinical transplantation

Published: August 15, 2024

Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD).

Correction: Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD).

Journal: Journal of translational medicine

Published: April 30, 2024

The Use of Genetic Testing in Nephrolithiasis Evaluation: A Retrospective Review From a Multidisciplinary Kidney Stone Clinic.

The Use of Genetic Testing in Nephrolithiasis Evaluation: A Retrospective Review From a Multidisciplinary Kidney Stone Clinic.

Journal: Urology

Published: April 17, 2024

79-Year-Old Woman With Nausea and Diarrhea.

79-Year-Old Woman With Nausea and Diarrhea.

Journal: Mayo Clinic proceedings

Published: December 14, 2023

The Value of Pharmacogenomics for White and Indigenous Americans after Kidney Transplantation.

The Value of Pharmacogenomics for White and Indigenous Americans after Kidney Transplantation.

Journal: Pharmacy (Basel, Switzerland)

Published: May 30, 2023

Endosomal trafficking inhibitor EGA can control TLR7-mediated IFNα expression by human plasmacytoid dendritic cells.

Endosomal trafficking inhibitor EGA can control TLR7-mediated IFNα expression by human plasmacytoid dendritic cells.

Journal: Frontiers in immunology

Published: April 07, 2023

Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD).

Implementation of genomic medicine for rare disease in a tertiary healthcare system: Mayo Clinic Program for Rare and Undiagnosed Diseases (PRaUD).

Journal: Journal of translational medicine

Published: February 22, 2023

Showing 1-12 of 60

Last Updated: 09/26/2026